galectin-slider-v1-670x220

News

Galectin Therapeutics Reports 2017 First Quarter Financial Results and Provides Business Update

May 15, 2017 | Press Release

Drug Development & Delivery, May 2017 issue: Targeting Galectin-3 Protein in Drug Development

May 3, 2017 | News Article

Galectin Therapeutics launches the Liver Line, an online community and publication on liver health and liver disease

May 3, 2017 | Press Release

Videos

Why did you choose to become the CEO of Galectin Therapeutics?

Are you conducting clinical trials with GR-MD-02? What results have you seen so far?

Can you give me a quick overview of Galectin Therapeutics and the opportunity it sees for GR-MD-02?

Why are the results of the GR-MD-02 psoriasis study so promising?

Why is the NASH-CX trial so important?

Galectin Therapeutics, Inc.

NASDAQ: GALT

Financial Tear Sheet
Filings & Reports

Stock price updates every 30 minutes.

Corporate Snapshot

Subscribe